Clinical trial

Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes

NCT02733211

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2019-03-01

PhaseNA

Study timeline

Study start (estimated)2019-03-01Date precision: month

Registry last updated2019-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesunresolved

Interventions

MD- Logic Closed Loop SystemDEVICE

sensor augmented pump therapyDEVICE

Sponsors & collaborators

Rabin Medical Centerlead sponsor

GIFcollaborator

Mapped research locations

HanoverGermany1 Petah TikvaIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02733211 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.